Cargando…

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy: Miniperspective

[Image: see text] Cyclin dependent kinase (CDK) inhibitors have been the topic of intense research for nearly 2 decades due to their widely varied and critical functions within the cell. Recently CDK9 has emerged as a druggable target for the development of cancer therapeutics. CDK9 plays a crucial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sonawane, Yogesh A., Taylor, Margaret A., Napoleon, John Victor, Rana, Sandeep, Contreras, Jacob I., Natarajan, Amarnath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2016
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636177/ https://www.ncbi.nlm.nih.gov/pubmed/27171036 http://dx.doi.org/10.1021/acs.jmedchem.6b00150

Ejemplares similares

Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase
por: Rana, Sandeep, et al.
Publicado: (2021)

The Essential Medicinal Chemistry of Curcumin: Miniperspective
por: Nelson, Kathryn M., et al.
Publicado: (2017)

Discovery and characterization of small molecule Rac1 inhibitors
por: Arnst, Jamie L., et al.
Publicado: (2017)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
por: Alsfouk, Aisha
Publicado: (2021)

Development of Synthetic Lethality Anticancer Therapeutics: Miniperspective
por: Fang, Bingliang
Publicado: (2014)

Targeting the Androgen Receptor with Steroid Conjugates: Miniperspective
por: Levine, Paul M., et al.
Publicado: (2014)

Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1): Miniperspective
por: Ye, Na, et al.
Publicado: (2014)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
por: Kour, Smit, et al.
Publicado: (2019)

Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agent
por: Hussain, Afzal, et al.
Publicado: (2017)

Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress: Miniperspective
por: Walensky, Loren D., et al.
Publicado: (2014)

Development of Safe and Effective Botanical Dietary Supplements: Miniperspective
por: van Breemen, Richard B.
Publicado: (2015)

Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationship of Substituted Quinazolinones as Cyclin-Dependent Kinase 9 Inhibitors
por: Alkahtani, Hamad M., et al.
Publicado: (2022)

Parallel Worlds of Public and Commercial Bioactive Chemistry Data: Miniperspective
por: Lipinski, Christopher A., et al.
Publicado: (2014)

Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
por: Robb, Caroline M., et al.
Publicado: (2017)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
por: Robb, Caroline M., et al.
Publicado: (2020)

Effects of Cyclin Dependent Kinase 9 inhibition on zebrafish larvae
por: Matrone, Gianfranco, et al.
Publicado: (2016)

Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs): Miniperspective
por: Kolarič, Anja, et al.
Publicado: (2020)

The ProTide Prodrug Technology: From the Concept to the Clinic: Miniperspective
por: Mehellou, Youcef, et al.
Publicado: (2017)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss: Miniperspective
por: Hazlitt, Robert A., et al.
Publicado: (2018)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action
por: Łukasik, Paweł, et al.
Publicado: (2021)

Structure–Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors
por: Sonawane, Yogesh A., et al.
Publicado: (2017)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
por: Rajput, Sandeep, et al.
Publicado: (2016)

Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases: Miniperspective
por: Ghaemmaghami, Sina, et al.
Publicado: (2014)

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
por: Kryštof, Vladimír, et al.
Publicado: (2012)

Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma
por: Tong, Zhimin, et al.
Publicado: (2017)

Efficient Activation of Reconstructed Rat Embryos by Cyclin-Dependent Kinase Inhibitors
por: Webb, Robin L., et al.
Publicado: (2010)

Cyclin-Dependent Kinase Inhibitors Induce Apoptosis in Plant Cells
por: Strnad, M., et al.
Publicado: (2001)

Purine Inhibitors of Cyclin-Dependent Kinase and Their Apoptosis and Cytotoxicity Mechanisms
por: Strnad, M., et al.
Publicado: (2001)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
por: Tavakolian, Shaian, et al.
Publicado: (2020)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
por: Saqub, Hera, et al.
Publicado: (2020)

Cyclin-Dependent Kinase 9 Activity Regulates Neutrophil Spontaneous Apoptosis
por: Wang, Keqing, et al.
Publicado: (2012)

The Current State of Drug Discovery and a Potential Role for NMR Metabolomics: Miniperspective
por: Powers, Robert
Publicado: (2014)

Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia
por: Yeh, Yuh-Ying, et al.
Publicado: (2014)

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
por: Hassan, Md Sazzad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7p70vvrjth164cp33675njtj5m